Elunetirom for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Sep 2024: Trial started, NCT06633016
  2. 9 Oct 2024: Trial registered, NCT06633016

The trials

NCT06633016: Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

State
Under way
Phase
Phase 2
People
230 planned
Started
20 Sep 2024
Primary completion
Jun 2026
Arms
ABX-002 + SSRI/SNRI
Results
None posted
  1. 20 Sep 2024: Trial started
  2. 9 Oct 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.